Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial.

MLA

Sampson, Hugh A., et al. “Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial.” JAMA: Journal of the American Medical Association, vol. 318, no. 18, Nov. 2017, pp. 1798–809. EBSCOhost, https://doi.org/10.1001/jama.2017.16591.

APA

Sampson, H. A., Shreffler, W. G., Yang, W. H., Sussman, G. L., Brown-Whitehorn, T. F., Nadeau, K. C., Cheema, A. S., Leonard, S. A., Pongracic, J. A., Sauvage-Delebarre, C., Assa, ad, A. H., de Blay, F., Bird, J. A., Tilles, S. A., Boralevi, F., Bourrier, T., Hébert, J., Green, T. D., van Wijk, R. G., & Knulst, A. C. (2017). Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial. JAMA: Journal of the American Medical Association, 318(18), 1798–1809. https://doi.org/10.1001/jama.2017.16591

Chicago

Sampson, Hugh A., Wayne G. Shreffler, William H. Yang, Gordon L. Sussman, Terri F. Brown-Whitehorn, Kari C. Nadeau, Amarjit S. Cheema, et al. 2017. “Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial.” JAMA: Journal of the American Medical Association 318 (18): 1798–1809. doi:10.1001/jama.2017.16591.